Nathan Krah is a hematology and oncology fellow at the University of Utah, where he also earned his MD/PhD. He completed his undergraduate studies at Bowdoin College and internal medicine residency at UCSF as part of the Molecular Medicine Program. His research focuses on the metabolic vulnerabilities of hematologic malignancies, including myelofibrosis and other myeloid neoplasms. He is particularly interested in how metabolic rewiring contributes to disease progression and therapeutic resistance in leukemia and MPNs. Dr. Krah is currently a joint trainee in the laboratories of Dr. Shannon Elf and Dr. Jared Rutter.